The study examined the association between Palliative radiotherapy and the improvement of the symptoms associated with
metastatic breast cancer. These include metastatic in the spinal cord and associated pain, brain metes and associated symptoms, bone
metes, Metastic in the lung and finally spread in organs such as liver and others. The study also dealt with the connection between
it and the improvement of the standard of life of the patient and toxic and other important factors and was achieved through a set of
international standards questionnaire by which the calibration of the result. The value of radiotherapy for palliation is well known
to oncologists but not necessarily to other physicians. Using terms such as symptom improvement ratio (SIR) than traditional
response rates might be more appropriate in describing the benefits of palliative radiotherapy to other health care professionals.
Late detection and spread of the disease in the late stages of breast cancer due to proliferation causes multiple symptoms this study
was conducted in the centre of tumours treatment in Sudan, represented in Khartoum oncology Hospital (RICK) in the period 2014
to 2017. The findings support the hypothesis that radiotherapy is an effective treatment for a proportion of patients with MBC
related pain, with 35% of assessable patients experiencing a clinically meaningful improvement in their pain. Of these, 12.5% had
a complete improvement in their pain. There were no specific features that differentiated the complete responders from the other
n patients Though this may be due to the small number of complete responders. There was no association between pain response
and improvement in any other symptoms, therefore, palliative radiotherapy in MBC should only be considered for pain control.
Keywords: Palliative radiotherapy; Symptoms improvement; Metastic breast cancer; Pain control